This protocol addresses osteomyelitis in an adult patient whose bone culture has returned positive for Pseudomonas aeruginosa — a finding that drives a specific, organism-directed antibiotic strategy rather than empiric broad-spectrum coverage.
Antibiotic selection is determined directly by the culture result. When bone culture confirms Pseudomonas aeruginosa, initial antibiotic therapy follows specific organism-targeted guidance rather than a generic osteomyelitis regimen.
The protocol specifies a targeted intravenous combination antibiotic regimen directed against Pseudomonas aeruginosa — the complete agent selection, combination strategy, and dosing are in the full protocol.